"TransRadial Ultra Support Technique" (TRUST)
- Conditions
- Coronary ArteriosclerosesCoronary Artery Disease
- Interventions
- Procedure: Anchoring TechniqueProcedure: TRUST techniqueProcedure: Coronary stenting
- Registration Number
- NCT03025685
- Lead Sponsor
- Meshalkin Research Institute of Pathology of Circulation
- Brief Summary
Adequate support is required for challenging percutaneous coronary interventions (PCI). The "TransRadial Ultra Support Technique" (TRUST technique) is a new support technique that provides active support by deep pass of the coronary wire into the heart cavities (left ventricle-LV, right ventricle-RV) or aorta.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 54
- Subjects singed informed consent form
- Subjects eligible for percutaneous coronary intervention
- Age <18 years or >75 years
- Subject has a platelet count < 100,000 cells/mm3 or > 700,000 cells/mm3.
- Known non-adherence to double anti-platelet therapy (DAPT)
- LVEF <30%
- Continuing bleeding
- Acute coronary syndrome (ST-elevation Myocardial infarction)
- Pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Anchoring technique + Coronary Stenting Anchoring Technique PCI with coronary stenting using Wire Anchoring Pass technique for support improvement TRUST technique + Coronary Stenting TRUST technique PCI with coronary stenting using TransRadial Ultra Support technique for support improvement Anchoring technique + Coronary Stenting Coronary stenting PCI with coronary stenting using Wire Anchoring Pass technique for support improvement TRUST technique + Coronary Stenting Coronary stenting PCI with coronary stenting using TransRadial Ultra Support technique for support improvement
- Primary Outcome Measures
Name Time Method Procedural success 1 week after PCI Device success without the occurrence of in-hospital MACCE
Device success Intraoperative Achievement of a final residual diameter stenosis \<20% and a TIMI 3 flow in the target vessel
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
State Research Institute of CIrculation Pathology
🇷🇺Novosibirsk, Russian Federation